Current Concepts in the Surgical Management of Pancreatic Cancer

Surgical Oncology Clinics of North America

Volumn 19, Issue 2, 2010, Pages 335-358

  Thomas, Ryan M ^a   Ahmad, Syed A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Pancreatic ductal adenocarcinoma; Perioperative care; Surgical resection; Surgical techniques

Indexed keywords

ANASTOMOSIS; CANCER MORTALITY; CANCER SURGERY; CLINICAL EVALUATION; HUMAN; LYMPH NODE DISSECTION; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; REVIEW; SURGICAL MORTALITY; TREATMENT OUTCOME; VASCULAR SURGERY;

CARCINOMA, PANCREATIC DUCTAL; HUMANS; PANCREATECTOMY; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 75849116018     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.11.001     Document Type: Review

References (93)

1. DiMagno E.P. Pancreatic cancer: clinical presentation, pitfalls and early clues. Ann Oncol 10 Suppl 4 (1999) 140-142
2. The M.D. Anderson surgical oncology handbook. 3rd edition (2003), Lippincott Williams & Wilkins, Philadelphia
3. Chari S.T., Leibson C.L., Rabe K.G., et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134 (2008) 95-101
4. Pannala R., Basu A., Petersen G.M., et al. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10 (2009) 88-95
5. Wong J.C., and Lu D.S. Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol 6 (2008) 1301-1308
6. Valls C., Andia E., Sanchez A., et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol 178 (2002) 821-826
7. Legmann P., Vignaux O., Dousset B., et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 170 (1998) 1315-1322
8. Prokesch R.W., Chow L.C., Beaulieu C.F., et al. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224 (2002) 764-768
9. Bipat S., Phoa S.S., van Delden O.M., et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 29 (2005) 438-445
10. Holalkere N.S., Sahani D.V., Blake M.A., et al. Characterization of small liver lesions: added role of MR after MDCT. J Comput Assist Tomogr 30 (2006) 591-596
11. Chang L., Stefanidis D., Richardson W.S., et al. The role of staging laparoscopy for intraabdominal cancers: an evidence-based review. Surg Endosc 23 (2009) 231-241
12. Warshaw A.L., Tepper J.E., and Shipley W.U. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 151 (1986) 76-80
13. Maithel S.K., Maloney S., Winston C., et al. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol 15 (2008) 3512-3520
14. Conlon K.C., Dougherty E., Klimstra D.S., et al. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 223 (1996) 134-140
15. Minnard E.A., Conlon K.C., Hoos A., et al. Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. Ann Surg 228 (1998) 182-187
16. Pisters P.W., Lee J.E., Vauthey J.N., et al. Laparoscopy in the staging of pancreatic cancer. Br J Surg 88 (2001) 325-337
17. Enestvedt C.K., Mayo S.C., Diggs B.S., et al. Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: is it cost-effective in the current era?. J Gastrointest Surg 12 (2008) 1177-1184
18. Dixon J.M., Armstrong C.P., Duffy S.W., et al. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24 (1983) 845-852
19. Nakayama T., Ikeda A., and Okuda K. Percutaneous transhepatic drainage of the biliary tract: technique and results in 104 cases. Gastroenterology 74 (1978) 554-559
20. Povoski S.P., Karpeh Jr. M.S., Conlon K.C., et al. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 230 (1999) 131-142
21. Sohn T.A., Yeo C.J., Cameron J.L., et al. Do preoperative biliary stents increase postpancreaticoduodenectomy complications?. J Gastrointest Surg 4 (2000) 258-267 [discussion: 267-8]
22. Pisters P.W., Hudec W.A., Hess K.R., et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234 (2001) 47-55
23. Hodul P., Creech S., Pickleman J., et al. The effect of preoperative biliary stenting on postoperative complications after pancreaticoduodenectomy. Am J Surg 186 (2003) 420-425
24. Sewnath M.E., Birjmohun R.S., Rauws E.A., et al. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 192 (2001) 726-734
25. Hatfield A.R., Tobias R., Terblanche J., et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 2 (1982) 896-899
26. McPherson G.A., Benjamin I.S., Hodgson H.J., et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71 (1984) 371-375
27. Pitt H.A., Gomes A.S., Lois J.F., et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?. Ann Surg 201 (1985) 545-553
28. Lai E.C., Mok F.P., Fan S.T., et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 81 (1994) 1195-1198
29. van der Gaag N.A., de Castro S.M., Rauws E.A., et al. Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial). BMC Surg 7 (2007) 3
30. Davids P.H., Groen A.K., Rauws E.A., et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340 (1992) 1488-1492
31. Kaassis M., Boyer J., Dumas R., et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 57 (2003) 178-182
32. Mullen J.T., Lee J.H., Gomez H.F., et al. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9 (2005) 1094-1104 [discussion: 1104-5]
33. Wasan S.M., Ross W.A., Staerkel G.A., et al. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol 100 (2005) 2056-2061
34. Whipple A.O., Parsons W.B., and Mullins C.R. Treatment of carcinoma of the ampulla of Vater. Ann Surg 102 (1935) 763-779
35. Hirono S., Tani M., Kawai M., et al. A central pancreatectomy for benign or low-grade malignant neoplasms. J Gastrointest Surg 13 9 (2009) 1659-1665
36. Roggin K.K., Rudloff U., Blumgart L.H., et al. Central pancreatectomy revisited. J Gastrointest Surg 10 (2006) 804-812
37. McClusky III D.A., Skandalakis L.J., Colborn G.L., et al. Harbinger or hermit? Pancreatic anatomy and surgery through the ages-part 3. World J Surg 26 (2002) 1512-1524
38. Traverso L.W., and Longmire Jr. W.P. Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 146 (1978) 959-962
39. Traverso L.W., and Longmire Jr. W.P. Preservation of the pylorus in pancreaticoduodenectomy: a follow-up evaluation. Ann Surg 192 (1980) 306-310
40. Tran K.T., Smeenk H.G., van Eijck C.H., et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240 (2004) 738-745
41. Seiler C.A., Wagner M., Bachmann T., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
42. Lin P.W., Shan Y.S., Lin Y.J., et al. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 52 (2005) 1601-1604
43. Paquet K.J. Comparison of Whipple's pancreaticoduodenectomy with the pylorus- preserving pancreaticoduodenectomy-a prospectively controlled, randomized long-term trial. Chirurg Gastroenterol 14 (1998) 54-58
44. Roder J.D., Stein H.J., Huttl W., et al. Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg 79 (1992) 152-155
45. Karanicolas P.J., Davies E., Kunz R., et al. The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard Whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol 14 (2007) 1825-1834
46. Diener M.K., Knaebel H.P., Heukaufer C., et al. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 245 (2007) 187-200
47. Kollmar O., Moussavian M.R., Richter S., et al. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial. Eur J Surg Oncol 34 (2008) 868-875
48. van Berge Henegouwen M.I., Akkermans L.M., van Gulik T.M., et al. Prospective, randomized trial on the effect of cyclic versus continuous enteral nutrition on postoperative gastric function after pylorus-preserving pancreatoduodenectomy. Ann Surg 226 (1997) 677-685 [discussion: 685-7]
49. van Berge Henegouwen M.I., van Gulik T.M., Akkermans L.M., et al. The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers. Gut 41 (1997) 758-762
50. Yeo C.J., Barry M.K., Sauter P.K., et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg 218 (1993) 229-237 [discussion: 237-8]
51. Ohwada S., Satoh Y., Kawate S., et al. Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy. Ann Surg 234 (2001) 668-674
52. Diener M.K., Heukaufer C., Schwarzer G., et al. Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2 (2008) CD006053
53. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228 (1998) 508-517
54. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 (2005) 618-628 [discussion: 628-30]
55. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg 9 (2005) 1191-1204 [discussion: 1204-6]
56. Iacono C., Accordini S., Bortolasi L., et al. Results of pancreaticoduodenectomy for pancreatic cancer: extended versus standard procedure. World J Surg 26 (2002) 1309-1314
57. Capussotti L., Massucco P., Ribero D., et al. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138 (2003) 1316-1322
58. Pawlik T.M., Abdalla E.K., Barnett C.C., et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140 (2005) 584-589 [discussion: 589-91]
59. Michalski C.W., Kleeff J., Wente M.N., et al. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94 (2007) 265-273
60. Fortner J.G., Kim D.K., Cubilla A., et al. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 186 (1977) 42-50
61. Tseng J.F., Raut C.P., Lee J.E., et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8 (2004) 935-949 [discussion: 949-50]
62. Leach S.D., Lee J.E., Charnsangavej C., et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85 (1998) 611-617
63. Fuhrman G.M., Leach S.D., Staley C.A., et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic tumor study group. Ann Surg 223 (1996) 154-162
64. Nakagohri T., Kinoshita T., Konishi M., et al. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186 (2003) 149-153
65. Howard T.J., Villanustre N., Moore S.A., et al. Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head. J Gastrointest Surg 7 (2003) 1089-1095
66. Yekebas E.F., Bogoevski D., Cataldegirmen G., et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247 (2008) 300-309
67. Conlon K.C., Labow D., Leung D., et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg 234 (2001) 487-493 [discussion: 493-4]
68. Kawai M., Tani M., Terasawa H., et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg 244 (2006) 1-7
69. Bassi C., Butturini G., Molinari E., et al. Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg 21 (2004) 54-59
70. Sarr M.G., and Pancreatic Surgery Group. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196 (2003) 556-564 [discussion: 564-5; author reply 565]
71. Shinchi H., Wada K., and Traverso L.W. The usefulness of drain data to identify a clinically relevant pancreatic anastomotic leak after pancreaticoduodenectomy?. J Gastrointest Surg 10 (2006) 490-498
72. Reid-Lombardo K.M., Farnell M.B., Crippa S., et al. Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the pancreatic anastomotic leak study group. J Gastrointest Surg 11 (2007) 1451-1458 [discussion: 1459]
73. Buchler M., Friess H., Klempa I., et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163 (1992) 125-130 [discussion: 130-1]
74. Friess H., Beger H.G., Sulkowski U., et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82 (1995) 1270-1273
75. Montorsi M., Zago M., Mosca F., et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117 (1995) 26-31
76. Lowy A.M., Lee J.E., Pisters P.W., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226 (1997) 632-641
77. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232 (2000) 419-429
78. Suc B., Msika S., Piccinini M., et al. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg 139 (2004) 288-294 [discussion: 295]
79. D'Andrea A.A., Costantino V., Sperti C., et al. Human fibrin sealant in pancreatic surgery: it is useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol 26 (1994) 283-286
80. Suc B., Msika S., Fingerhut A., et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial. Ann Surg 237 (2003) 57-65
81. Lillemoe K.D., Cameron J.L., Kim M.P., et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 8 (2004) 766-772 [discussion: 772-4]
82. Neoptolemos J.P., Stocken D.D., Dunn J.A., et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234 (2001) 758-768
83. Merchant N.B., Rymer J., Koehler E.A., et al. Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?. J Am Coll Surg 208 (2009) 829-838 [discussion: 838-41]
84. Staley C.A., Cleary K.R., Abbruzzese J.L., et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12 (1996) 373-380
85. Raut C.P., Tseng J.F., Sun C.C., et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246 (2007) 52-60
86. Birkmeyer J.D., Warshaw A.L., Finlayson S.R., et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 126 (1999) 178-183
87. Begg C.B., Cramer L.D., Hoskins W.J., et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280 (1998) 1747-1751
88. Porter G.A., Pisters P.W., Mansyur C., et al. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol 7 (2000) 484-489
89. Kennedy E.P., Rosato E.L., Sauter P.K., et al. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution-the first step in multidisciplinary team building. J Am Coll Surg 204 (2007) 917-923 [discussion: 923-4]
90. Kow A.W., Chan S.P., Earnest A., et al. Striving for a better operative outcome: 101 pancreaticoduodenectomies. HPB (Oxford) 10 (2008) 464-471
91. Deziel D.J., Wilhelmi B., Staren E.D., et al. Surgical palliation for ductal adenocarcinoma of the pancreas. Am Surg 62 (1996) 582-588
92. Van Heek N.T., De Castro S.M., van Eijck C.H., et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 238 (2003) 894-902 [discussion: 902-5]
93. Lillemoe K.D., Cameron J.L., Hardacre J.M., et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230 (1999) 322-328 [discussion: 328-30]